What is CTA EU?
The purpose of a CTA is to provide all the important details about the clinical trial to the health authorities in order to obtain the product approval. In the European Union (EU), the CTAs are regulated under the Clinical Trial Regulation EU No. 536/2014.
What does EU CTR stand for?
European Clinical Trial Register
This document provides answers to the most frequently asked questions received on the EudraCT database and on its public interface, the European Clinical Trial Register (EU CTR).
What is CTA submission?
A Clinical Trials Application (CTA) is the application/submission to the competent National. Regulatory Authority(ies) for authorization to conduct a clinical trial in a specific country.
What is ANVISA approval?
The National Health Surveillance Agency or ANVISA (Agência Nacional de Vigilância Sanitária) is the Brazilian regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices, among others.
What is the difference between IB and Impd?
Investigator’s Brochure (IB) stands as one of the important documents for clinical trial applications (CTAs) which includes part of the data to be presented in the IMPD. Referring to the IB for the preclinical and clinical sections, the IMPD can be prepared.
Is a CTA the same as an IND?
What is the difference between IND and CTA submissions? Preclinical studies are essential for the development of all drug candidates. In general, CTAs contain fewer study documents than INDs, and hence require less preparation time.
When did EU Ctr take effect?
The European Commission confirmed 31 January 2022 as the date of entry into application of the Clinical Trials Regulation (CTR) and the go-live of the Clinical Trials Information System (CTIS).
What are the benefits of the EU CTR?
Other key benefits of the Regulation include:
- improving information-sharing and collective decision-making on clinical trials;
- increasing transparency of information on clinical trials;
- ensuring high standards of safety for all participants in EU clinical trials.
What is an IND called in Canada?
Investigational New Drug
My trial was filed as an Investigational New Drug (IND) submission prior to September 1, 2001. Do amendments have to be filed? Yes, amendments have to be filed. Investigational New Drug (IND) submissions filed prior to September 1, 2001 are not subject to Part C, Division 5 of the Food and Drug Regulations.
What is the difference between IMPD and CTA?
The IMPD is the main document of the CTA in the EU used for obtaining the authorization to conduct a clinical trial with an IMP.